Marimed (MRMD) Common Equity (2011 - 2026)
Marimed (MRMD) posted quarterly Common Equity of $46.5 million for Q1 2026, down 19.56% year-over-year from $57.8 million in Q1 2025, and down 6.99% quarter-over-quarter from $50.0 million in Q4 2025.
Marimed (MRMD) Common Equity (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Common Equity for 16 consecutive years, with $46.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 19.56% year-over-year to $46.5 million; the TTM figure through Mar 2026 stood at $46.5 million (down 19.56% YoY), while the FY2025 annual figure was $50.0 million, down 14.58% from the prior year.
- Common Equity slipped to $46.5 million in Q1 2026 per MRMD's latest filing, from $50.0 million in the prior quarter.
- Across five years, Common Equity topped out at $80.9 million in Q2 2023 and bottomed at $1.1 million in Q3 2025.
- Historically, Common Equity has averaged $57.0 million across 5 years, with a median of $57.8 million in 2025.
- Annual changes were most pronounced in 2022 — Common Equity soared 196.47% — and 2025, when it plunged 98.37%.
- Marimed's Common Equity stood at $57.3 million in 2022, then increased by 20.2% to $68.9 million in 2023, then retreated by 15.01% to $58.5 million in 2024, then declined by 14.58% to $50.0 million in 2025, then dropped by 6.99% to $46.5 million in 2026.
- Business Quant data shows MRMD's Common Equity at $46.5 million in Q1 2026, $50.0 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 43.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.24 Mn |
| Mar 31, 2026 | 46.51 Mn |
| Dec 31, 2025 | 50.01 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 56.94 Mn |
| Mar 31, 2025 | 57.82 Mn |
| Dec 31, 2024 | 58.55 Mn |
| Sep 30, 2024 | 67.84 Mn |
| Jun 30, 2024 | 67.33 Mn |
| Mar 31, 2024 | 67.69 Mn |
| Dec 31, 2023 | 68.89 Mn |
| Sep 30, 2023 | 79.86 Mn |
| Jun 30, 2023 | 80.90 Mn |
| Mar 31, 2023 | 65.27 Mn |
| Dec 31, 2022 | 57.31 Mn |
| Sep 30, 2022 | 51.88 Mn |
| Jun 30, 2022 | 47.45 Mn |
| Mar 31, 2022 | 43.59 Mn |
| Dec 31, 2021 | 36.30 Mn |
| Sep 30, 2021 | 35.30 Mn |